Gumisad, Eddie .
HRN: 28-64-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2026
CEFTRIAXONE 1G (VIAL)
03/04/2026
03/10/2026
IV
2G
OD
CAP-MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: